中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs

文献类型:期刊论文

作者Mao, Yu2; Zhang, Xiaodong2; Li, Li1; Yuan, Bojun2; Lu, Guocal2
刊名REGULATORY TOXICOLOGY AND PHARMACOLOGY
出版日期2008-02
卷号50期号:1页码:75-86
关键词LZB subchronic toxicity toxicokinetics 13-week oral administration beagle dogs
ISSN号0273-2300
DOI10.1016/j.yrtph.2007.10.006
文献子类Article
英文摘要The subchronic toxicity and toxicokinetics of a novel proton pump inhibitor, pymeprazole (LZB), were investigated in beagle dogs by daily oral administration for 13 consecutive weeks. Three test groups received doses of 30, 100 and 300 mg/kg/day of LZB. Rabeprazole of 60 mg/kg/day was used as positive control. The 13-week repeated oral doses of LZB resulted in objective signs of mild gastrointestinal disturbance for high-close group animals. One individual dog of high-dose group was found to be lethargy and astasia at the last month of administration; for hematology, mild anemia was observed at high-dose females; for clinical chemistry, higher cholest, trigly and gastrin were observed at high-dose females, higher ASAT, ALAT, cholesterol, triglyceride and gastrin at high-dose males were also observed; for histopathology, the primary effects of LZB were related to gastric mucosa of high-dose group seen by H and E or Grimelius stain. Impairment of surface epithelium was observed by SEM. The treat-related effects basically were reversible for a 4-week drug-free period. As for positive control group, 13-week oral administration of rabeprazole resulted in more severe toxicity than high-dose group of LZB although much lower dose was employed. The accumulation of LZB after 13-week oral administration was not notable at the toxic dose of 300 mg/kg/day. The toxic dose was considered to be 100 mg/kg/day and the no-observed-adverse-effect level (NOAEL) to be 30 mg/kg/day, which is much higher than other PPIs. The toxicological target could be stomach, liver, hematological system and nervous system. (c) 2007 Elsevier Inc. All rights reserved.
WOS关键词ACID-RELATED DISORDERS ; OMEPRAZOLE ; SECRETION ; SAFETY ; PANTOPRAZOLE ; RATS
WOS研究方向Legal Medicine ; Pharmacology & Pharmacy ; Toxicology
语种英语
WOS记录号WOS:000252632800007
出版者ACADEMIC PRESS INC ELSEVIER SCIENCE
源URL[http://119.78.100.183/handle/2S10ELR8/273001]  
专题上海药物代谢研究中心
通讯作者Yuan, Bojun
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Metab Pharmacokinet, Shanghai 201203, Peoples R China
2.Mil Med Univ 2, Ctr Evaluat Drug Safety, Shanghai 200433, Peoples R China;
推荐引用方式
GB/T 7714
Mao, Yu,Zhang, Xiaodong,Li, Li,et al. Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs[J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY,2008,50(1):75-86.
APA Mao, Yu,Zhang, Xiaodong,Li, Li,Yuan, Bojun,&Lu, Guocal.(2008).Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs.REGULATORY TOXICOLOGY AND PHARMACOLOGY,50(1),75-86.
MLA Mao, Yu,et al."Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs".REGULATORY TOXICOLOGY AND PHARMACOLOGY 50.1(2008):75-86.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。